NewAmsterdam Pharma Grants Options to New Hires
The inducement grants were approved by the Compensation Committee for six non-executive employees and vest over multiple years.
Updated on Nov. 6, 2026 in People
NewAmsterdam Pharma approved grants of 106,600 inducement share options and 28,295 restricted stock units to six non-executive new hires on November 2, 2026. The grants were announced on November 6, 2026.
Why it matters
Inducement grants are used to attract new employees by offering equity as an incentive for accepting employment. The grants tie recipients' compensation to the company's share price and long-term performance.
The 106,600 share options carry an exercise price of $19.56, matching the Nasdaq closing price on the grant date, while 28,295 restricted stock units were also granted to the six recipients. The filing does not disclose the grants' total value or their percentage of outstanding shares.
The players
NewAmsterdam Pharma
NewAmsterdam Pharma is a biopharmaceutical company headquartered in Naarden, the Netherlands, with a Miami presence, whose ordinary shares trade on the Nasdaq exchange.
The details
The Compensation Committee of NewAmsterdam Pharma's Board of Directors approved the grants under the company's 2024 Inducement Plan. The share options vest over four years, with 25% vesting at the one-year anniversary, while the restricted stock units vest in equal thirds at one, two and three years.
Timeline
November 2, 2026: Grants were made and the closing share price of $19.56 on Nasdaq was set as the exercise price.
November 6, 2026: NewAmsterdam announced the inducement grants.
Market Landscape
Inducement grants under Nasdaq Listing Rule 5635(c)(4) let listed companies compensate new hires with equity without a shareholder vote. NewAmsterdam's use of this exemption follows a common practice among Nasdaq-listed biopharmaceutical firms competing for scarce talent.
For shareholders, the grants add potential dilution as the options and units vest over three to four years. Employees who accept such offers gain a financial stake in the company's future share price.
The takeaway
Equity-based inducement awards are a standard recruiting tool, and investors can track their dilutive effect through a company's periodic filings. Vesting schedules determine when recipients gain ownership and when shares may enter circulation.
Further reading
Explore more on People coverage across the United States business landscape.
Source note: This article includes information reported by The Manila times.
